"Adenosine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter.
| Descriptor ID |
D000241
|
| MeSH Number(s) |
D03.633.100.759.590.138 D13.570.583.138 D13.570.800.096
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Adenosine".
Below are MeSH descriptors whose meaning is more specific than "Adenosine".
This graph shows the total number of publications written about "Adenosine" by people in this website by year, and whether "Adenosine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
| 1996 | 2 | 1 | 3 |
| 1997 | 2 | 3 | 5 |
| 1998 | 2 | 1 | 3 |
| 1999 | 4 | 1 | 5 |
| 2000 | 4 | 4 | 8 |
| 2001 | 4 | 6 | 10 |
| 2002 | 2 | 1 | 3 |
| 2004 | 3 | 3 | 6 |
| 2005 | 5 | 0 | 5 |
| 2006 | 1 | 3 | 4 |
| 2007 | 5 | 1 | 6 |
| 2008 | 2 | 1 | 3 |
| 2009 | 6 | 0 | 6 |
| 2010 | 7 | 2 | 9 |
| 2011 | 1 | 1 | 2 |
| 2012 | 9 | 5 | 14 |
| 2013 | 1 | 0 | 1 |
| 2014 | 3 | 2 | 5 |
| 2015 | 4 | 5 | 9 |
| 2016 | 6 | 4 | 10 |
| 2017 | 3 | 4 | 7 |
| 2018 | 2 | 4 | 6 |
| 2019 | 4 | 3 | 7 |
| 2020 | 2 | 3 | 5 |
| 2021 | 3 | 5 | 8 |
| 2022 | 3 | 8 | 11 |
| 2023 | 3 | 3 | 6 |
| 2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adenosine" by people in Profiles.
-
N6-methyladenosine modification is not a general trait of viral RNA genomes. Nat Commun. 2024 Mar 11; 15(1):1964.
-
In mild to moderate COVID-19, VV116 safely reduced time to sustained clinical symptom resolution. Ann Intern Med. 2024 03; 177(3):JC35.
-
Exploring the Expression of Adenosine Pathway-Related Markers CD73 and CD39 in Colorectal and Pancreatic Carcinomas Characterized by Multiplex Immunofluorescence: A Pilot Study. Pathobiology. 2024; 91(3):205-218.
-
Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer. J Immunother Cancer. 2023 10; 11(10).
-
METTL3-mediated N6-methyladenosine exacerbates ferroptosis via m6A-IGF2BP2-dependent mitochondrial metabolic reprogramming in sepsis-induced acute lung injury. Clin Transl Med. 2023 09; 13(9):e1389.
-
CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer. Cancer Res. 2023 04 04; 83(7):1111-1127.
-
Comparative Study of Adenosine Analogs as Inhibitors of Protein Arginine Methyltransferases and a Clostridioides difficile-Specific DNA Adenine Methyltransferase. ACS Chem Biol. 2023 04 21; 18(4):734-745.
-
Second-Generation CD73 Inhibitors Based on a 4,6-Biaryl-2-thiopyridine Scaffold. ChemMedChem. 2023 04 03; 18(7):e202200594.
-
A2A receptor signaling drives cisplatin-mediated hippocampal neurotoxicity and cognitive defects in mice. Purinergic Signal. 2023 12; 19(4):591-593.
-
Systematic Design of Adenosine Analogs as Inhibitors of a Clostridioides difficile-Specific DNA Adenine Methyltransferase Required for Normal Sporulation and Persistence. J Med Chem. 2023 01 12; 66(1):934-950.